( S...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S407000, C546S312000

Reexamination Certificate

active

07932256

ABSTRACT:
The invention relates to the compound (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile, pharmaceutical compositions of the compound, and methods of using the compound for the treatment of psychiatric disorders and neurological diseases including depression, anxiety related disorders, irritable bowel syndrome, addiction and negative aspects of drug and alcohol withdrawal, and other conditions associated with CRF.

REFERENCES:
patent: 6159980 (2000-12-01), Arvanitis et al.
patent: WO 2004/046136 (2004-06-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, 205.
Hackam, et al. JAMA, 296(14), 2006, 1731-1732.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

( S... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with ( S..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ( S... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2718790

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.